Clinical Trial Update: IMMNC-HF: IntraMyocardial Injection of Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for IMMNC-HF investigating intraMYocardial injection of bone marrow mononuclear cells in heart failure patients across Phase 1 and Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• IMMNC-HF (bone marrow mononuclear cells)

Snippet

Sponsor: SCARM Institute, Tabriz, Iran | Conditions: Heart Failure | Phase 1, Phase 2 | Status: UNKNOWN